Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
Mounjaro pen is a GLP-1 receptor agonist used for weight loss and blood sugar regulation
Upon completion, participants will be able to: Explain the mechanisms of action, therapeutic effects, and limitations of GLP-1 RAs Develop individualized treatment plans that integrate GLP-1 RA therapy with lifestyle interventions to support sustainable weight loss and improve management of related comorbidities Apply best practices in medication titration, side effect management, and patient counseling to support safe and sustainable care Click here to enroll for free
Additionally, those receiving Vitamin B12 injections in Severna Park, MD , frequently note improvements in their mental clarity and overall well-being
BBA Clin 3:123125
It always comes quickly in the mail